Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemicAshraf S. Harahsheh, Jane C. Burns, Nagib Dahdah et al.|The Journal of Pediatrics|2020Cited by 112
Medium‐Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease RegistryBrian W. McCrindle, Claudia Renaud, Cedric Manlhiot et al.|Journal of the American Heart Association|2020Cited by 89
Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease RegistryMatthew D. Elias, Audrey Dionne, Brian W. McCrindle et al.|CJC Open|2020Cited by 86
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter studySupriya S Jain, Andrew L. Cheng, Steven A. Anderson et al.|EClinicalMedicine|2024Cited by 28
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry TrialCedric Manlhiot, S. Kristen Sexson Tejitel, Jane W. Newburger et al.|Canadian Journal of Cardiology|2020Cited by 22